HSBC Holdings’s SpringWorks Therapeutics SWTX Stock Holding History

HSBC Holdings’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,062	Closed	-$332K	–	3116
2025 Q2	$332K	Buy	+7,062	New	+$314K	﹤0.01%	2380
2024 Q3	–	Sell	-7,357	Closed	-$275K	–	3151
2024 Q2	$275K	Buy	7,357 +183	+3%	+$7.7K	﹤0.01%	2346
2024 Q1	$353K	Buy	+7,174	New	+$332K	﹤0.01%	2320

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

HSBC Holdings's SWTX Position: Q3 2025 in Review

HSBC Holdings sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 7,062 shares — an estimated $332K sold.

HSBC Holdings first reported a position in SWTX in Q1 2024 and held it in 3 quarters. The position peaked at $353K in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

HSBC Holdings reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
HSBC Holdings sold 7,062 SpringWorks Therapeutics shares in Q3 2025, an estimated $332K.
HSBC Holdings first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 3 quarters.
HSBC Holdings's SpringWorks Therapeutics position peaked at $353K in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.